170 related articles for article (PubMed ID: 10622182)
1. Signalling pathways in the brain: cellular transduction of mood stabilisation in the treatment of manic-depressive illness.
Manji HK; McNamara R; Chen G; Lenox RH
Aust N Z J Psychiatry; 1999 Dec; 33 Suppl():S65-83. PubMed ID: 10622182
[TBL] [Abstract][Full Text] [Related]
2. Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness.
Manji HK; Lenox RH
Biol Psychiatry; 1999 Nov; 46(10):1328-51. PubMed ID: 10578449
[TBL] [Abstract][Full Text] [Related]
3. Lithium regulates PKC-mediated intracellular cross-talk and gene expression in the CNS in vivo.
Chen G; Masana MI; Manji HK
Bipolar Disord; 2000 Sep; 2(3 Pt 2):217-36. PubMed ID: 11249800
[TBL] [Abstract][Full Text] [Related]
4. Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers.
Manji HK; Moore GJ; Chen G
Br J Psychiatry Suppl; 2001 Jun; 41():s107-19. PubMed ID: 11450170
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder.
Hahn CG; Friedman E
Bipolar Disord; 1999 Dec; 1(2):81-6. PubMed ID: 11252663
[TBL] [Abstract][Full Text] [Related]
6. [On the relevance of protein kinase C to lithium therapy in bipolar disorder].
Sela B
Harefuah; 2004 Jun; 143(6):414-6, 462. PubMed ID: 15524097
[TBL] [Abstract][Full Text] [Related]
7. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness.
Manji HK; Moore GJ; Chen G
Biol Psychiatry; 2000 Oct; 48(8):740-54. PubMed ID: 11063971
[TBL] [Abstract][Full Text] [Related]
8. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness.
Manji HK; Moore GJ; Chen G
J Clin Psychiatry; 2000; 61 Suppl 9():82-96. PubMed ID: 10826666
[TBL] [Abstract][Full Text] [Related]
9. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
[TBL] [Abstract][Full Text] [Related]
10. A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients.
Moore GJ; Cortese BM; Glitz DA; Zajac-Benitez C; Quiroz JA; Uhde TW; Drevets WC; Manji HK
J Clin Psychiatry; 2009 Apr; 70(5):699-705. PubMed ID: 19389332
[TBL] [Abstract][Full Text] [Related]
11. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
[TBL] [Abstract][Full Text] [Related]
12. Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients.
Hahn CG; Umapathy ; Wang HY; Koneru R; Levinson DF; Friedman E
J Psychiatr Res; 2005 Jul; 39(4):355-63. PubMed ID: 16044535
[TBL] [Abstract][Full Text] [Related]
13. [Predictors of prophylactic response to lithium].
Rohayem J; Baylé JF; Richa S
Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
[TBL] [Abstract][Full Text] [Related]
14. Lithium and synaptic plasticity.
Salinas PC; Hall AC
Bipolar Disord; 1999 Dec; 1(2):87-90. PubMed ID: 11252664
[TBL] [Abstract][Full Text] [Related]
15. Glycogen synthase kinase-3: a target for novel bipolar disorder treatments.
Gould TD; Zarate CA; Manji HK
J Clin Psychiatry; 2004 Jan; 65(1):10-21. PubMed ID: 14744163
[TBL] [Abstract][Full Text] [Related]
16. Lithium and the brain: a psychopharmacological strategy to a molecular basis for manic depressive illness.
Lenox RH; Watson DG
Clin Chem; 1994 Feb; 40(2):309-14. PubMed ID: 8313612
[TBL] [Abstract][Full Text] [Related]
17. Regulation of signal transduction pathways by mood-stabilizing agents: implications for the delayed onset of therapeutic efficacy.
Manji HK; Chen G; Hsiao JK; Risby ED; Masana MI; Potter WZ
J Clin Psychiatry; 1996; 57 Suppl 13():34-46; discussion 47-8. PubMed ID: 8970503
[TBL] [Abstract][Full Text] [Related]
18. Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants.
Chen G; Hasanat KA; Bebchuk JM; Moore GJ; Glitz D; Manji HK
Psychosom Med; 1999; 61(5):599-617. PubMed ID: 10511011
[TBL] [Abstract][Full Text] [Related]
19. Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder.
Einat H; Manji HK
Biol Psychiatry; 2006 Jun; 59(12):1160-71. PubMed ID: 16457783
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks.
Lenox RH; Wang L
Mol Psychiatry; 2003 Feb; 8(2):135-44. PubMed ID: 12610644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
